Andrew Sassine

Andrew Sassine

Directeur Financier/CFO chez
Arcturus Therapeutics Ltd.

Fortune : 2 M $ au 31/05/2026

61 ans
Finance
Health Technology
Technology Services

Profil

Andrew H.
Sassine
is currently Chief Financial Officer & Director at Arcturus Therapeutics, Inc. since 2019 and Chief Financial Officer & Director at Arcturus Therapeutics Ltd. since 2019.
Former roles include Chief Financial Officer & Director at Arcturus Therapeutics Holdings, Inc. from 2019 to 2025; Independent Non-Employee Director at MYnd Analytics, Inc.; Independent Director at Acorn Energy, Inc. from 2013 to 2014; Director at Meditech, Inc.; Director at Freedom Meditech, Inc.; Independent Director at FluoroPharma Medical, Inc. from 2014 to 2016; Independent Director at iCAD, Inc. from 2015 to 2025; Director at ComHear, Inc. from 2014 to 2015; Director at MD Revolution, Inc.; Independent Director at Gemphire Therapeutics, Inc. from 2015 to 2019; Independent Director at Exicure, Inc. from 2021 to 2022; Principal at Continental Bank Corp.; Portfolio Manager at Fidelity Management & Research Co. LLC from 1999 to 2011; Portfolio Manager at Fidelity Investments, Inc. from 1999 to 2012; Portfolio Manager at Heller Financial, Inc. from 1995 to 1997; Vice President-Acquisition Finance Group at Fleet National Bank from 1997 to 1999; Vice President-Acquisition Finance Group at Fleet Bank of Massachusetts, NA; Trustee at Clarke Schools for Hearing & Speech from 2009 to 2014; and Member at Henry B. Tippie College of Business.
Education includes an undergraduate degree from the University of Iowa in 1987 and an MBAistration from The Wharton School of the University of Pennsylvania in 1993.

Détentions connues dans des sociétés publiques

SociétéDateNombre d'actionsValorisationDate de valorisation
16/04/2026 221 764 ( 0,82% ) 2 M $ 31/05/2026

Postes actifs de Andrew Sassine

SociétésPosteDébut
Directeur Financier/CFO 24/08/2018
Directeur Financier/CFO 01/01/2019

Anciens postes connus de Andrew Sassine

SociétésPosteFin
ARCTURUS THERAPEUTICS HOLDINGS INC. Directeur Financier/CFO 11/12/2025
ICAD Directeur/Membre du Conseil 17/07/2025
EXICURE, INC. Directeur/Membre du Conseil 04/02/2022
METAVIA INC. Directeur/Membre du Conseil 30/12/2019
FLUOROPHARMA MEDICAL, INC. Directeur/Membre du Conseil 08/01/2016
Voir l'expérience en détail de Andrew Sassine

Formation de Andrew Sassine

Expériences
Fonctions occupées

Actives

Inactives

Sociétés cotées

Entreprise privées

Relations

69

Relations au 1er degré

23

Entreprises liées au 1er degré

Homme

Femme

Administrateurs

Exécutifs

Sociétés liées

Entreprise privées23

Finance

Finance

Finance

Health Services

Health Technology

Technology Services

Consumer Services

Finance

Electronic Technology

Meditech, Inc.

Health Technology

Commercial Services

Consumer Services

Consumer Services

Technology Services

Health Services

Technology Services

Health Technology

Finance

Finance

Health Technology

Health Technology

Health Technology

  1. Bourse
  2. Insiders
  3. Andrew Sassine
- 40% : Les Meilleurs Outils Réservés aux Abonnés pour Identifier les Meilleurs Investissements de Demain !
j
:
:
PROFITEZ-EN MAINTENANT